Investor Relations
Board Committees
Our board of directors currently has three standing committees, consisting of an audit committee, a corporate governance committee, and an independent directors committee.
Audit Committee
Our audit committee currently is composed of Arnold J. Wasserman and Keith Hall. Our board of directors has determined that Mr. Wasserman is an "audit committee financial expert," as such term is defined by the SEC and is the committee Chairman. The audit committee is primarily concerned with the accuracy and effectiveness of the audits of our financial statements by our internal audit staff and by our independent auditors. Its duties include:
· Selecting and retaining the independent auditors, as well as ascertaining the auditors' independence;
· Reviewing the scope of the audits to be conducted, as well as the results of their audits;
· Approving non-audit services provided to our company by the independent auditors;
· Reviewing the organization and scope of our internal system of audit, financial and disclosure controls;
· Appraising our financial reporting activities, including our Annual Report on Form 10-K, and the accounting standards and principles followed;
· And conducting other reviews relating to compliance by employees with our internal policies and applicable laws.
Corporate Governance
Our corporate governance committee currently is composed of Thomas Wasserman and Arnold J. Wasserman. The duties of our corporate governance committee include overseeing that our board's policies, as well as ensuring that we are in compliance with all applicable federal and state securities laws and the Nasdaq rules, and determining our board of directors' slate of director-nominees for each shareholder election of directors.
Independent Directors Committee
Our independent directors committee is composed of Arnold J. Wasserman and Keith Hall. The duties of our independent directors committee include the review and approval of all transactions with related parties, in particular conducting negotiations with respect to potential financing transactions where conflicts of interest may occur.
